close

Login

Library
Shopping Cart
Remember Me
Forgot password/Login issues?
loading animation for AJAX calls
 
 
Direct (781) 489-7301,  Toll Free (866) 285-7215

Search

Search
BCC Advance Search

Synthetic Biology: Emerging Global Markets

  • Published: November 2011
  • |
  • Report Code: BIO066B

REPORT HIGHLIGHTS

The global value of the synthetic biology market reached $1.1 billion in 2010. It is expected to reach $1.6 billion in 2011 and it will further grow to $10.8 billion by 2016, increasing at a compound annual growth rate (CAGR) of 45.8.%.

SAMPLE FIGURE
GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY PRODUCT TYPE, 2010-2016
($ MILLIONS)
GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY PRODUCT TYPE, 2010-2016
To Contact us, click here  help


Source: BCC Research

Download Free Chapter

REPORT SCOPE

SCOPE AND FORMAT

The study’s scope includes core synthetic biology products (synthetic genes, other DNA parts, chassis organisms, synthetic cells), enabling technologies (DNA sequencing, oligonucleotides, specialty media, bioinformatics), and enabled technologies (biofuels, specialty chemicals, diagnostics, pharmaceuticals, agriculture) that are already commercial or forecast to be commercialized within the next 5 years.

We analyze key synthetic biology technologies and products to determine present and future market status, and forecast growth from 2011 through 2016. We also discuss strategic alliances, industry structures, competitive dynamics, patent strategy, and market driving forces.

BCC examines the synthetic biology industry by market segment, including suppliers of synthetic genes, enzymes, pharmaceutical companies, biofuels, and specialty chemicals.  The role of key strategic alliances from 2009 through 2011 is discussed.  Emerging markets including synthetic genes, synthetic biology-enabled drugs and vaccines, and chassis organisms are analyzed, as well as metabolically-engineered factories for producing synthetic fuels and specialty chemicals.  The main companies in these fields are highlighted.  

ANALYST CREDENTIALS

The author, John Bergin, has written previous BCC biotechnology reports entitled Epigenomics:  Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics; Global Biochip Markets:  Microarrays and Lab-on-a-chip; RNA Interference in the Post-Genomics Era:  Markets and Technologies; DNA Sequencing: Emerging Technologies and Markets; and Biologic Imaging Reagent: Future Technologies and Markets.  Mr. Bergin has held business development, sales, and marketing positions with a Fortune 500 advanced materials company as well as executive management positions with an emerging nanotechnology company.  Mr. Bergin holds the following degrees: B.S. Chemistry, M.S. Biotechnology, and Masters of Business Administration.


Download Free Chapter

REPORT TOC

download table of contents
Pricing on the website is provided for single users and 2-5 users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at (+1)781-489-7301 or send an email to information@bccresearch.com
  Title/Chapter Name Pages Price
Synthetic Biology: Emerging Global Markets 279 $4655
Chapter- 1: INTRODUCTION - Complimentary 5 $0
  Show Details
Chapter- 2: SUMMARY 3 $250
  Show Details
Chapter- 3: OVERVIEW 9 $225
  Show Details
Chapter- 4: SYNTHETIC BIOLOGY TECHNOLOGIES 57 $1427
  Show Details
Chapter- 5: SYNTHETIC BIOLOGY APPLICATIONS 19 $476
  Show Details
Chapter- 6: SYNTHETIC BIOLOGY INDUSTRY 45 $1126
  Show Details
Chapter- 7: SYNTHETIC BIOLOGY MARKETS 41 $1026
  Show Details
Chapter- 8: PATENTS 14 $350
  Show Details
Chapter- 9: COMPANY PROFILES 86 $2152
  Show Details
 
  List of Tables
  List of Figures
 
Also See
BIO066A - June 2009
Latest Version
BIO066C - June 2014
Select License type:

Original Price $6650
Offer Price $4655

buy now
download free chapter
Want to find out more
about this report?
request more info
Get Notified
on all the latest research reports
Subscribe

Choose your License

loading animation for AJAX calls